193. Prader-Willi syndrome Clinical trials / Disease details


Clinical trials : 111 Drugs : 120 - (DrugBank : 30) / Drug target genes : 51 - Drug target pathways : 103

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03848481
(ClinicalTrials.gov)
November 23, 202019/2/2019CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)Cannabidivarin (CBDV) vs. Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)Prader-Willi SyndromeDrug: CBDV Compound;Drug: PlaceboMontefiore Medical CenterFoundation for Prader-Willi Research;GW Pharmaceuticals Ltd.Recruiting5 Years30 YearsAll26Phase 2United States